| Corticosteroid Reduction in COPD (NCT02857842) | Chronic Obstructive Pulmonary Disease Trial Network, Denmark | 2016-08-01 |
| The Effect of Non-invasive Ventilation on the Oxygenation of Peripheral Muscle in Hypercapnic COPD Patients (NCT02877290) | Schön Klinik Berchtesgadener Land | 2016-08-01 |
| Respiratory Pathogens of Patients With Asthma and COPD Exacerbations (NCT02866357) | Chinese University of Hong Kong | 2016-08-01 |
| Study of the Effect on Clinical Outcomes Using Secure Text Messaging (NCT02568514) | University of Pennsylvania | 2016-08-01 |
| Observational Study of Obstructive Lung Disease (NOVELTY) (NCT02760329) | AstraZeneca | 2016-07-25 |
| Adjuvant Therapy for Severe COPD Patients in the Stable Phase by an Oxyhydrogen Generator With Nebulizer (NCT02850185) | Shanghai Asclepius Meditec Inc. | 2016-07-15 |
| Comparison of 3-Minute Step Test (3MStepT) and 6-Minute Walk Test (6MWT) in COPD Patients (NCT02873780) | Centre Hospitalier des Pays de Morlaix | 2016-07-01 |
| Preliminary Testing of the Vitaliti CVSM Wearable, Vitaliti Spirotoscope, and Vitaliti IVD Station (NCT02856633) | Cloud DX Inc. | 2016-07-01 |
| Effect of Neuromuscular Electrical Stimulation Versus Cycle Ergometer Training in a Pulmonary Rehabilitation Program (NCT02656667) | University Hospital, Brest | 2016-06-08 |
| Potentially Avoidable Hospitalisation in France (NCT02898155) | University Hospital, Montpellier | 2016-06-01 |
| Prevalence of Respiratory Aspiration in Patients With COPD (NCT02722629) | Hospital Italiano de Buenos Aires | 2016-06-01 |
| Ultibro® Versus Spiriva® Alone to Reduce Exertional Dyspnea in Patients With Moderate to Severe COPD (NCT02567214) | Laval University | 2016-06-01 |
| Health Effects of Secondhand Smoke Exposure in Outdoor Smoking Areas in Patients With COPD and Asthma ( TackSHSWP5 ) (NCT03074734) | Institut Català d'Oncologia | 2016-06-01 |
| Proteoglycan 4 Mechanism the Effectiveness of Pulmaonry Recovery in COPD Patients (NCT02764658) | Taipei Medical University | 2016-05-01 |
| EIT Study With COPD and OHS Patients (EIT Step 2) (NCT02765360) | Guy's and St Thomas' NHS Foundation Trust | 2016-05-01 |
| Novel Therapies for Muco-Obstructive Lung Diseases: Testing the Transnasal Pulmonary Delivery Device in COPD/CB Subjects (NCT02341183) | University of North Carolina, Chapel Hill | 2016-05-01 |
| Effect of Postextubation High-Flow Nasal Cannula vs Noninvasive Ventilation in Patients With Hypercapnic COPD (NCT03928535) | Xiangya Hospital of Central South University | 2016-05-01 |
| Development of a MID for the 1-minute Sit-to-stand Test (NCT02708719) | Schön Klinik Berchtesgadener Land | 2016-04-01 |
| Clinical Pharmacology Study to Evaluate the Total Systemic Exposure and the Lung Availability of CHF 5993 in Healthy Volunteers (NCT02743013) | Chiesi Farmaceutici S.p.A. | 2016-04-01 |
| Effects of Osteopathic Techniques on Residual Volume in Severe Chronic Obstructive Pulmonary Disease (NCT02755363) | Medical University of Warsaw | 2016-04-01 |
| High Flow Nasal Cannula and Exercise in Chronic Obstructive Pulmonary Disease (COPD) (NCT02858960) | Hospital Italiano de Buenos Aires | 2016-04-01 |
| Comparative Study on Usability of Inhaler Devices in Adults With Asthma or COPD (NCT02757209) | Consorzio Futuro in Ricerca | 2016-04-01 |
| Metabolism and Oxygen Consumption During Functional Electrical Stimulation Cycling in COPD (NCT02594722) | University Hospital, Rouen | 2016-04-01 |
| High Flow Nasal Cannula and Exercise Testing in Chronic Obstructive Pulmonary Disease (COPD) (NCT02860273) | Hospital Italiano de Buenos Aires | 2016-04-01 |
| Autologous Stem Cell Treatment for Chronic Lung Disease Study (NCT03044431) | Lung Institute | 2016-04-01 |
| RELVAR Effects on Parasternal Muscle Activity, Diaphragm, and Ventilation in Severe COPD (NCT02989935) | University of Calgary | 2016-04-01 |
| Biomarkers for Diagnosis and Treatment of COPD (NCT02633280) | University of Catanzaro | 2016-04-01 |
| Troponin T in Chronic Obstructive Pulmonary Disease (COPD) Patients After Physical Exercise (NCT02721693) | LHL Helse | 2016-04-01 |
| Transtheoretical Model Based Nursing Interventions on Smoking Cessation in Patients With COPD (NCT04313738) | Dokuz Eylul University | 2016-04-01 |
| Effect of Losartan on Airway Mucociliary Dysfunction in Patients With COPD and Chronic Bronchitis (NCT02416102) | University of Miami | 2016-03-31 |
| nCD64 vs. Neutrophil/Lymphocyte Ratio for Predicting In-hospital Outcome in AE-COPD (NCT03146611) | Assiut University | 2016-03-11 |
| Assessment of Rheological Parameters of Human Sputum. (NCT02682290) | University Hospital, Grenoble | 2016-03-03 |
| Randomized Evaluation of Default Access to Palliative Services (NCT02505035) | University of Pennsylvania | 2016-03-01 |
| Mobile Integrated Healthcare and Community Paramedicine (NCT05061433) | Rhode Island Hospital | 2016-02-08 |
| Electrical Stimulation for Attenuating Muscle Atrophy (NCT02321163) | The Hong Kong Polytechnic University | 2016-02-01 |
| Airway Effects of Tiotropium in Patients With COPD (NCT02683668) | Imperial College London | 2016-02-01 |
| Prevalence of Sleep Disordered Breathing in a Lung Cancer Screening Cohort (NCT02687997) | Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz | 2016-02-01 |
| EMG in COPD - Factor Analysis (NCT02721199) | Guy's and St Thomas' NHS Foundation Trust | 2016-01-01 |
| Intelligent Oxygen Therapy During Activities of Daily Living (NCT02683486) | Imperial College London | 2016-01-01 |
| Repeat Emergency Department Visits Among Patients With Asthma and COPD (NCT02499887) | State University of New York at Buffalo | 2016-01-01 |
| Pharmacokinetic Interaction and the Safety of Inhaled CHF5259 and CHF6001 (NCT03004495) | Chiesi Farmaceutici S.p.A. | 2016-01-01 |
| The Pittsburgh Vitamin D Study: Vitamin D Supplementation in Vitamin D-deficient Subjects at Risk of Lung Cancer (NCT02532062) | University of Pittsburgh | 2016-01-01 |
| Inspiratory Muscle Training on Respiratory Muscle Function，Quality of Life and Exercise Capacity in Stable COPD (NCT03101774) | Guangzhou Institute of Respiratory Disease | 2016-01-01 |
| A Study to Assess the Effects of PT003 and Placebo MDI on Specific Image Based Airway Volumes and Resistance in Subjects With Moderate to Severe COPD (NCT02643082) | Pearl Therapeutics, Inc. | 2015-12-23 |
| Prevalence of COPD in Our Lung Cancer Population, Compared to Controls (NCT02603627) | Guy's and St Thomas' NHS Foundation Trust | 2015-12-01 |
| HealtheRx Survey for Pulmonary Research Registry Recruitment (NCT02653066) | University of Chicago | 2015-12-01 |
| FiO2 in Chronic Obstructive Pulmonary Disease (COPD) Patient Normobaric O2 Versus NIV (NCT02599246) | Breas Medical S.A.R.L. | 2015-11-17 |
| The Effect of Physical Activity Promotion on Short and Long-term Outcomes in COPD (NCT02099799) | VA Office of Research and Development | 2015-11-17 |
| Nasal High Flow Therapy 30 Day Readmission Study (NCT02552732) | Fisher and Paykel Healthcare | 2015-11-01 |
| Validation of French Version of LCADL and Dyspnea-12 (NCT02555202) | University Hospital, Brest | 2015-10-15 |
| Assessment of Switching From Salmeterol/Fluticasone to Indacaterol/Glycopyrronium in a symtomaticCOPD Patient Cohort (NCT02516592) | Novartis Pharmaceuticals | 2015-10-13 |
| Counseling During Pulmonary Rehabilitation (NCT02455206) | Zurich University of Applied Sciences | 2015-10-01 |
| Effect of Aclidinium/Formoterol on Nighttime Lung Function and Morning Symptoms in Chronic Obstructive Pulmonary Disease (NCT02429765) | Queen's University | 2015-10-01 |
| Study to Determine the Amount of Glycopyrrolate Absorbed in the Lungs After Taking the Medicine With a eFlow Nebulizer and Seebri® Breezhaler® With and Without Activated Charcoal in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD). (NCT02512302) | Sunovion Respiratory Development Inc. | 2015-10-01 |
| Circulating Micro RNAs Expression in Egyptian Bronchial Asthma and COPD Patients (NCT02719145) | Tanta University | 2015-10-01 |
| Physiotherapy in Acute Exacerbation of Chronic Obstructive Pulmonary Disease (NCT02515318) | Universidad de Granada | 2015-09-01 |
| Assessment of Bronchodilator Efficacy of Formoterol/Budesonide 12/400 mcg Via Discair in COPD (NCT03028701) | Neutec Ar-Ge San ve Tic A.Ş | 2015-09-01 |
| Physiotherapy in Patients With Stable Chronic Obstructive Pulmonary Disease (NCT02517411) | Universidad de Granada | 2015-09-01 |
| Nasal, Tracheal and Bronchial Mucosal Lining Fluid(MLF) Sampling From Patients With Respiratory Diseases (NCT02807025) | Imperial College Healthcare NHS Trust | 2015-09-01 |
| The Economic Burden of Chronic Obstructive Pulmonary Disease(COPD) in South Korea (NCT02750189) | Konkuk University Medical Center | 2015-09-01 |
| A Randomized, Double-Blind, Parallel-Group, 24-Week, Chronic-Dosing, Multi-Center Study to Assess the Efficacy and Safety of PT010, PT003, and PT009 Compared With Symbicort® Turbuhaler® (Kronos) (NCT02497001) | Pearl Therapeutics, Inc. | 2015-08-10 |
| Effects of Exhalation Valve on the Lack of Air and Exercise Tolerance in Patients With COPD (NCT02566915) | Hospital de Clinicas de Porto Alegre | 2015-08-01 |
| Pilot Study of Physiological Effect of High-Flow Nasal Cannula on Respiratory Pattern and Work of Breathing (NCT02514798) | Tufts Medical Center | 2015-07-01 |
| Evaluation of Novel Lung Function Parameters in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT02827721) | Universitätsmedizin Mannheim | 2015-07-01 |
| Efficacy of Nebulized Pulmicort Respules in Primary Lung Cancer Patients With COPD (NCT02504801) | Xiuyi Zhi | 2015-07-01 |
| Study to Assess the Efficacy and Safety of PT010 Relative to PT003 and PT009 in Subjects With Moderate to Very Severe COPD (Ethos) (NCT02465567) | Pearl Therapeutics, Inc. | 2015-06-30 |
| Effects of Ramadan Observance in Male Patients With Chronic Obstructive Pulmonary Disease (NCT03604952) | Faculty of Medicine, Sousse | 2015-06-18 |
| Biomarker Assay Validation in Healthy Smokers and COPD Smokers and Ex-smokers (NCT02490358) | Respivert Ltd | 2015-06-01 |
| Adipose Derived Stem Cells Transplantation for Chronic Obstructive Pulmonary Disease (NCT02645305) | University of Science Ho Chi Minh City | 2015-06-01 |
| Lung Function Decline and Disease Risk From Young Adulthood to Middle Age (NCT02245178) | Northwestern University | 2015-06-01 |
| A Prospective Observational Study of the Breath Responsive Variable Bolus Oxygen Conserving Device (NCT02627599) | StratiHealth | 2015-05-01 |
| High Risk Populations Among COPD Patients in Japan (NCT02413359) | AstraZeneca | 2015-05-01 |
| Symptom-driven Maintenance and Reliever Treatment to Prevent Exacerbations in COPD (NCT02477397) | University Medical Center Groningen | 2015-05-01 |
| Crossover Study to Assess the Efficacy of PT003 With and Without a Valved Holding Chamber in Subjects With Moderate to Severe COPD (NCT02454959) | Pearl Therapeutics, Inc. | 2015-05-01 |
| Pilot Study of Safety and Tolerability of Nutrifriend Cachexia in COPD Cachexia (NCT02442908) | Smartfish AS | 2015-05-01 |
| An Open Study to Assess the Robustness of the CRC749 Inhaler (NCT02474017) | Mylan Pharma UK Ltd. | 2015-05-01 |
| Cardiopulmonary Exercise Testing to Evaluate Pulmonary AVMs With and Without Airflow Obstruction (NCT02458703) | Imperial College London | 2015-05-01 |
| Exercise Training in Severe COPD (NCT02522637) | Fondazione Salvatore Maugeri | 2015-05-01 |
| Integrative-omics of the Disordered COPD Small Airway Epithelium (NCT02183818) | Weill Medical College of Cornell University | 2015-04-06 |
| Evaluation of the Effects of Whole Body Vibration on the Lung Function of Patients With Stable COPD (NCT02679677) | Heidelberg University | 2015-04-01 |
| The Trajectory of Physical Activity Following Pulmonary Rehabilitation (NCT02399254) | Trinity Health Of New England | 2015-04-01 |
| Comparison of High-flow Oxygen vs. BiPAP in Type II (Hypercapnic) Respiratory Failure (NCT03443479) | Hôpital de Verdun | 2015-04-01 |
| Observational Multicenter Non-interventional Study on COPD Patients Treatment Strategies at the Time of Hospital Discharge and Within 12 Months of Follow-up on an Outpatient Primary Care Basement (NCT02346292) | AstraZeneca | 2015-03-31 |
| Evaluation of a Multi-professional Breathlessness Service for Patients With Breathlessness Due to Any Advanced Disease (NCT02622412) | Ludwig-Maximilians - University of Munich | 2015-03-02 |
| Exercise Training in Patients With Mild COPD (NCT02930421) | Pontificia Universidad Catolica de Chile | 2015-03-01 |
| Meditative Movement for COPD Symptoms in Non-Smoking Flight Attendants (NCT02612389) | Dartmouth-Hitchcock Medical Center | 2015-03-01 |
| Short Term Physiological Effects of Nasal High Flow Oxygen on Respiratory Mechanics (NCT02363920) | IRCCS Azienda Ospedaliero-Universitaria di Bologna | 2015-03-01 |
| Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD (GOLDEN-4) (NCT02347774) | Sunovion Respiratory Development Inc. | 2015-02-01 |
| Assessment of Lung Perfusion in Patients With Chronic Obstructive Pulmonary Disease Using FD MRI (NCT02367209) | University Hospital, Basel, Switzerland | 2015-02-01 |
| Copenhagen Comorbidity in HIV Infection Study (NCT02382822) | Susanne Dam Nielsen, MD, DMSc | 2015-02-01 |
| Aerogen Nebuliser Versus Standard Nebulised Therapy in Acute Chronic Obstructive Pulmonary Disease (NCT02379065) | Chelsea and Westminster NHS Foundation Trust | 2015-02-01 |
| Innovations in Respiratory Muscles Training in Patients With Chronic Obstructive Pulmonary Disease. (INNOTORIO) (NCT02935166) | Fundación Cardiovascular de Colombia | 2015-02-01 |
| Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD (NCT02347761) | Sunovion Respiratory Development Inc. | 2015-02-01 |
| 24-hour Lung Function in Subjects With Moderate to Very Severe COPD After Treatment With PT003 and Placebo MDI (NCT02347085) | Pearl Therapeutics, Inc. | 2015-02-01 |
| Health-promoting Competence, Coping and Quality of Life in Patients With COPD (NCT02479841) | Helse Fonna | 2015-02-01 |
| Alpha-1 Carrier Genomics Study (NCT02810327) | Medical University of South Carolina | 2015-02-01 |
| 24-hour Lung Function in Subjects With Moderate to Very Severe COPD After Treatment With PT003, Open-Label Spiriva® Respimat® as an Active Control, and Placebo (NCT02347072) | Pearl Therapeutics, Inc. | 2015-02-01 |
| Expansion of the COPD At-risk Module in 4 States BRFSS Telephone Health Surveys (NCT02991391) | Duke University | 2015-01-01 |
| Is Patients With Pulmonary Disease Benefit a Program With Yogic Exercises? (NCT02233114) | Karolinska Institutet | 2015-01-01 |
| PSG Versus Oxim-capnography to Setup Home NIV (NCT02444806) | Guy's and St Thomas' NHS Foundation Trust | 2015-01-01 |